Table 1 Baseline characteristics (n = 215)
Characteristic | ||
|---|---|---|
Age, years, mean (SD) | 37.2 (9.8) | |
Sex, n (%) | ||
Male | 208 (96.7) | |
Female | 7 (3.3) | |
Weight, kg, mean (SD) | 65.2 (12.1) | |
HBV, n (%) | ||
Seronegative | 124 (57.7) | |
Current infection | 13 (6.1) | |
Seropositive inactive | 78 (36.3) | |
Active HCV infection, n (%) | 6 (2.8) | |
AIDS onset, n (%) | 23 (10.7) | |
Treatment regimen, n (%) | ||
DTG + (TDF/FTC or TAF/FTC) | 113 (52.6) | |
DTG/ABC/3TC | 59 (27.4) | |
RAL + (TDF/FTC or TAF/FTC) | 20 (9.3) | |
EVG/cobi/TAF/FTC | 17 (7.9) | |
Others | 6 (2.8) | |
HIV-RNA viral load, copies/mL, median (IQR) | 62,400 (18,500–151,500) | |
CD4+ cell count, cells/µL, median (IQR) | 314 (133–455.5) | |
eGFR, mL/min/1.73 m2, median (IQR) | 90.9 (78.2–102.5) | |